What serology tests are available for HBV?
A common point of confusion with hepatitis B virus (HBV) is interpretation of serology testing, the results of which vary depending on the clinical situation (e.g. acute / chronic / resolved infection, prior vaccination, etc.) For our purposes, we are interested in the antigens and corresponding antibodies listed in the figure below.


- HBcAg is not measurable in the blood, thus we can’t test for it on serology
- The virologist who discovered HBeAg chose the letter e for enigma
- An “acute hepatitis panel” in Epic at our hospitals includes 4 tests: HBsAg, IgM anti-HBc, and antibodies to HAV and HCV
- HBV persists in the body of all patients with infection, even those with evidence of serological recovery (e.g. a patient with positive anti-HBs and positive total anti-HBc.) This explains why anyone with a history of HBV infection who receives immunosuppressive therapy is at risk for HBV reactivation and a flare of HBV disease.
How should we think about seroconversion?

Early in an infection, unbound antigen exceeds the amount of bound antibodies. After seroconversion, antibodies exceed antigen, so there is a detectable amount of free antibody while all the antigen is bound and undetectable.
Seroconversion makes it unusual to see positive HBsAg and positive anti-HBs at the same time (or positive HBeAg with positive anti-HBe at the same time.)
How would you interpret the following HBV serology results?
Case 1
- negative HBsAg
- negative total anti-HBc
- negative anti-HBs
Case 2
- negative HBsAg
- negative total anti-HBc
- positive anti-HBs
Case 3
- negative HBsAg
- positive total anti-HBc
- positive anti-HBs
Case 4
- positive HBsAg
- positive total anti-HBc
- positive IgM anti-HBc
- negative anti-HBs
Case 5
- positive HBsAg
- positive total anti-HBc
- negative IgM anti-HBc
- negative anti-HBs
Want to know more? Check out CDC’s great videos on hepatitis serologies!
Who should be screened for HBV?
- People born in countries with HBV prevalence ≥2%
- People born in the US not vaccinated as infants whose parents were born in regions with high rates of HBV infection (i.e. regions with HBsAg prevalence ≥8%)
- Men who have sex with men
- People who inject drugs
- People with HIV
- Household and sexual contacts of HBV-infected people
- People requiring immunosuppressive therapy
- People with ESRD, including anyone on dialysis
- Blood and tissue donors
- People with elevated ALT levels (>19 IU/L for women and >30 IU/L for men)
- Pregnant women (recommended screening with HBsAg only)
- Infants born to HBV-infected mothers (recommended screening with HBsAg and anti-HBs)
Who should receive the HBV vaccine?
- All unvaccinated children <19yo
- Sex partners of HBsAg-positive people
- Sexually active people who are not in long-term, mutually monogamous relationships
- People seeking evaluation or treatment for an STI
- Men who have sex with men
- People who inject drugs
- Household contacts of HBsAg-positive people
- Residents/staff of facilities for developmentally disabled patients
- Healthcare and public safety workers with reasonably anticipated risk for exposure to blood or blood-contaminated body fluids
- People with ESRD, including anyone on dialysis
- International travelers to regions with intermediate or high levels of HBV infection
- People with chronic liver disease (e.g. cirrhosis, fatty liver disease, alcoholic liver disease, autoimmune hepatitis, and ALT or AST level >2x ULN)
- People with HCV infection or HIV infection
- Unvaccinated adults with diabetes mellitus aged 19-59yo (at the clinician’s discretion if ≥60yo)
- Incarcerated persons
- All other people who wish to be vaccinated